IGF-1 LR3 (lab sample AM20260925-17) was tested at 99.17% HPLC purity by Accumark Labs (Anaheim, California), analysis completed Oct 1, 2026; report 5CA9-GKY9 is verifiable at accumarklabs.com.
Chromatogram redrawn from Accumark Labs' data for report 5CA9-GKY9. Purity on this certificate is the lab's figure; it excludes the unretained solvent peak near the start of the run. View the original report on Accumark Labs (opens in new tab)
Accumark LabsCertificate of Analysis · Anaheim, CaliforniaReport 5CA9-GKY9
HPLC purity 99.17%: in the lab's chromatogram, 99.17% of the detected peak area belongs to the IGF-1 LR3 peak and the remaining 0.83% to other components the method detected.
Accumark Labs printed a purity specification of > 98.0% and marked the result "Conforms".
Measured content of IGF-1 LR3: the amount Accumark Labs quantified in the vial it received (0.078 mg). It is a measurement of this sample, not a label figure.
Identity: IGF-1 LR3, "Conforms". Accumark Labs' identity test matched the sample to IGF-1 LR3.
Mass spectrometry is not reported on this certificate.
How to verify report 5CA9-GKY9
Open the report from the "Full report" link. It opens on accumarklabs.com, Accumark Labs' own site, not a file hosted by us.
Check that the lab's page shows report 5CA9-GKY9.
Check the lot: AM20260925-17.
Check the analysis completion date: Oct 1, 2026.
Compare the figures with this certificate: HPLC purity 99.17%; IGF-1 LR3 0.078 mg.
Purity comes from reverse-phase HPLC with UV detection: the target peak's share of total detected area, measured per vial. What HPLC shows and how to read it.
IGF-1 LR3 is supplied for laboratory research purposes only. Not intended for human or veterinary use, diagnostic procedures, or clinical applications.